The future is 'PARP' - Phase-II-activity of PARP inhibitor among patients with BRCA-deficient breast cancer

A. Tutt, M. Robson, J. E. Garber, S. M. Domchek, M. W. Audeh, J. N. Weitzel, M. Friedlander, B. Arun, N. Loman, R. K. Schmutzler, A. Wardley, G. Mitchell, H. Earl, M. Wickens, J. Carmichael, Cornelia Liedtke

Research output: Contribution to journal › Comment/debate › peer-review

1 Scopus citations

Fingerprint

Dive into the research topics of 'The future is 'PARP' - Phase-II-activity of PARP inhibitor among patients with BRCA-deficient breast cancer'. Together they form a unique fingerprint.